• Accelerating TB vaccine Research & Development through partnership
  • TBVI TBVI TBVI
    • Home
    • About us
      • TBVI at a glance
      • Mission
      • Organisation
        • Governance Board
        • Advisory Committee
        • Steering Committee
        • Operational Office
        • Product and Clinical Development Team
        • Portfolio Management Committee
      • TBVI consortium
      • Key achievements and impact
      • Financials
      • Policies
    • What we do
      • Pipeline of vaccines
      • Research & Development
      • Services
    • How we work
      • Business model
      • Partnership
    • For partners
      • For researchers and vaccine developers
        • Partners pages
        • Access to services
      • MTBVAC in Newborns
        • Coordinator and partners
        • News and Publications
        • Communication tools
      • MTBVACN3
        • Work packages
        • Governance
        • The consortium and its partners
        • Publications and news
        • Acknowledgement
      • TBVAC2020
        • Word from the chair
        • TBVAC2020 project overview and achievements
        • TBVAC2020 project members
        • TBVAC2020 scientific publications
        • TBVAC2020 other publications
      • For funders
        • TBVI R&D priorities and funding opportunities
        • TBVI service provision and funding opportunities
        • Why invest in TBVI
    • News
    • Contact us:

    Advisory Committee

    Home / About us / Organisation / Advisory Committee
    • Prof Mark Hatherill (Chair)
      Prof Mark Hatherill (Chair)Director, South African Tuberculosis Vaccine Initiative (SATVI), University of Cape Town
      • Dr Carol Holm-Hansen
        Dr Carol Holm-HansenSenior scientist, Norwegian Institute of Public Health Oslo, Norway
        • Prof  Willem Hanekom
          Prof Willem HanekomDirector of the Africa Health Research Institute (AHRI) in KwaZulu-Natal, South Africa.
          • Dr Gerd Zettlmeissl
            Dr Gerd ZettlmeisslFormer CEO Valneva SE (formerly Intercell AG) Vienna, Austria
            • Ingrid Murillo Jelsbak
              Ingrid Murillo JelsbakClinical Research Director at Biofabri, Porriño, Spain
              • Frank Cobelens, MD MSc PhD
                Frank Cobelens, MD MSc PhDProfessor of Global Health at the Amsterdam University Medical Centers, loc. AMC, UvA, & Amsterdam Inst. for Global health & Devel. (AIGHD)
                • Ole F. Olesen, M.Sc, HD, Ph.D, FRCP(Edin)
                  Ole F. Olesen, M.Sc, HD, Ph.D, FRCP(Edin)Executive Director of the European Vaccine Initiative (EVI)
                  • Morten Ruhwald. MD, PhD
                    Morten Ruhwald. MD, PhDHead of TB program, Foundation of Innovative New Diagnostics (FIND).
                    • Dr Eugene Sun
                      Dr Eugene SunSenior Vice President, Research and Development for the TB Alliance
                      • Dr Thomas Nyirenda MD MPH
                        Dr Thomas Nyirenda MD MPHStrategic Partnerships and Capacity Development Manager of EDCTP
                        • Ann M. Ginsberg, M.D., Ph.D.
                          Ann M. Ginsberg, M.D., Ph.D.Deputy Director, TB Vaccines, the Bill & Melinda Gates Foundation
                          • Mercè Amat
                            Mercè AmatR&D manager Archivel Farma
                            • Dr Gerald Voss
                              Dr Gerald VossScientific Director
                              • Dr Nick Drager
                                Dr Nick DragerExecutive Director
                              Menu
                              • Home
                              • About us
                              • What we do
                              • How we work
                              • For researchers and vaccine developers
                              • For funders
                              • Pipeline of vaccines
                              • News
                              TuBerculosis Vaccine Initiative (TBVI)

                              Runderweg 6
                              8219 PK Lelystad
                              The Netherlands
                              Email: info@tbvi.eu
                              Phone: +31 320 277 550

                              © 2015 TuBerculosis Vaccine Initiative (TBVI) | ALL RIGHTS RESERVED | Disclaimer | Sitemap | Door Internetbureau Redkiwi

                              Start typing and press Enter to search

                              Cookies

                              This website uses cookies that help the website function

                              OK No